View in EDS HTML Full Text

MSD ed Endocyte annunciano le opinioni positive del CHMP europeo su VYNFINIT® (vintafolide) e sugli agenti complementari di imaging FOLCEPRI® (etarfolatide) e NEOCEPRI® (acido folico (IV) iniettabile)...

Saved in:
Bibliographic Details
Title: MSD ed Endocyte annunciano le opinioni positive del CHMP europeo su VYNFINIT® (vintafolide) e sugli agenti complementari di imaging FOLCEPRI® (etarfolatide) e NEOCEPRI® (acido folico (IV) iniettabile)...
Authors: Merck
Source: Business Wire (Italian). 03/22/2014.
Abstract: MSD ed Endocyte annunciano le opinioni positive del CHMP europeo su VYNFINIT® (vintafolide) e sugli agenti complementari di imaging FOLCEPRI® (etarfolatide) e NEOCEPRI® (acido folico (IV) iniettabile) nelle pazienti con carcinoma ovarico platino-resistente [ABSTRACT FROM PUBLISHER]
Database: Regional Business News
Full text is not displayed to guests.
FullText Text:
  Availability: 1
Header DbId: bwh
DbLabel: Regional Business News
An: bizwire.c54078074
AccessLevel: 6
PubType: News
PubTypeId: newspaperArticle
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MSD ed Endocyte annunciano le opinioni positive del CHMP europeo su VYNFINIT® (vintafolide) e sugli agenti complementari di imaging FOLCEPRI® (etarfolatide) e NEOCEPRI® (acido folico (IV) iniettabile)...
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Merck%22">Merck</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Business+Wire+%28Italian%29%22">Business Wire (Italian)</searchLink>. 03/22/2014.
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: MSD ed Endocyte annunciano le opinioni positive del CHMP europeo su VYNFINIT® (vintafolide) e sugli agenti complementari di imaging FOLCEPRI® (etarfolatide) e NEOCEPRI® (acido folico (IV) iniettabile) nelle pazienti con carcinoma ovarico platino-resistente [ABSTRACT FROM PUBLISHER]
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=bwh&AN=bizwire.c54078074
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: ita
        Text: Italian
    Titles:
      – TitleFull: MSD ed Endocyte annunciano le opinioni positive del CHMP europeo su VYNFINIT® (vintafolide) e sugli agenti complementari di imaging FOLCEPRI® (etarfolatide) e NEOCEPRI® (acido folico (IV) iniettabile)...
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Merck
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 03
              Text: 03/22/2014
              Type: published
              Y: 2014
          Titles:
            – TitleFull: Business Wire (Italian)
              Type: main
ResultId 1